UCB (BE.UCB) - 96.6 EUR (%)

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 95.7200 EUR
Ask 96.5800 EUR
Minim 95.6200 EUR
Maxim 96.8800 EUR
Pret referinta 95.6600
Volum -
Volum ultima zi 1
Max 52 sapt 96.8800 EUR
Min 52 sapt 65.5800 EUR

Descriere companie

Ucb SA (https://www.ucb.com/) is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Informatii companie

Nume

UCB

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.